series-a
Stage
2
Investors
About
One Biosciences develops AI-powered, clinical-grade single-cell profiling technology to deliver detailed tumor analysis from FFPE or frozen samples, aiding therapeutic development and clinical decision-making.
Explore One Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.